San Diego, CA, United States of America

Jennifer Lu

This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2024-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jennifer Lu. Retrieved from https://idiyas.com/inventor/jennifer-lu-61nz56kv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 22.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2024-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jennifer Lu

Introduction

Jennifer Lu is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of treatments for cystic fibrosis. With a total of 2 patents to her name, her work has garnered attention in the scientific community.

Latest Patents

Jennifer Lu's latest patents focus on crystalline forms of CFTR modulators. These patents disclose crystalline forms of Compound I, including pharmaceutically acceptable salts, solvates, and hydrates. Additionally, her patents cover pharmaceutical compositions that comprise these crystalline forms, methods of treating cystic fibrosis using these compositions, and methods for making them.

Career Highlights

Jennifer Lu is currently employed at Vertex Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her work is crucial in the ongoing fight against cystic fibrosis, a genetic disorder that affects the lungs and digestive system.

Collaborations

Some of her notable coworkers include Yi Shi and Kevin Gagnon, who collaborate with her on various projects within the company.

Conclusion

Jennifer Lu's innovative work in the pharmaceutical industry highlights her dedication to improving treatments for cystic fibrosis. Her contributions are paving the way for advancements in medical science and patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…